View Older Stories View More Recent Stories

Nov 19, 2021 09:55AM Arvinas and Pfizer Announce Updated Phase 1 Dose Escalation Data for ARV-471 to be Presented in Spotlight Poster Session at 2021 San Antonio Breast Cancer Symposium
Nov 19, 2021 09:55AM Arvinas and Pfizer Announce Updated Phase 1 Dose Escalation Data for ARV-471 to be Presented in Spotlight Poster Session at 2021 San Antonio Breast Cancer Symposium
Nov 19, 2021 08:25AM Pfizer (PFE), BioNTech (BNTX) Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Nov 19, 2021 08:25AM Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Nov 19, 2021 08:25AM Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Nov 18, 2021 01:30PM Pfizer’s XELJANZ® (tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis
Nov 18, 2021 06:45AM Pfizer (PFE) Announces Agreement to Supply 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to US Govt
Nov 18, 2021 06:45AM Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19
Nov 17, 2021 09:40AM Pfizer Completes Acquisition of Trillium Therapeutics
Nov 17, 2021 06:46AM Pfizer (PFE) Announces CFO Retirement
Nov 17, 2021 06:45AM Pfizer Announces Retirement of Chief Financial Officer Frank D’Amelio
Nov 17, 2021 01:05AM Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer
Nov 17, 2021 01:05AM Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer
Nov 16, 2021 02:00PM Pfizer (PFE) Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate
Nov 16, 2021 02:00PM Pfizer Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate
Nov 16, 2021 06:46AM Pfizer (PFE) Announces Licensing Agreement with Medicines Patent Pool (MPP) for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries
Nov 16, 2021 06:45AM Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries
Nov 11, 2021 11:00AM Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana
Nov 10, 2021 10:00AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Nov 9, 2021 07:51AM Biohaven Pharma (BHVN) Announces Strategic Collaboration with Pfizer (PFE) for Commercialization of Rimegepant Outside the US
Nov 9, 2021 07:46AM Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
Nov 5, 2021 06:45AM Pfizer's (PFE) COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study
Nov 5, 2021 06:45AM Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study
Oct 29, 2021 05:46PM Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children Aged 5-11
Oct 29, 2021 05:45PM Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Oct 29, 2021 05:45PM Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Oct 28, 2021 06:58AM Pfizer And BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs
Oct 28, 2021 06:45AM US Govt Purchases Additional 50M Doses of Pfizer (PFE) and BioNTech (BNTX) COVID-19 Vaccine
Oct 28, 2021 06:45AM Pfizer and BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs
Oct 27, 2021 05:51AM FDA AdCom Votes in Favor of Emergency Use Authorization for Pfizer (PFE) and BioNTech's (BNTX) Covid-19 Vaccine in Children 5 to <12 Years
Oct 26, 2021 06:19PM FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
Oct 26, 2021 06:19PM FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine in Children 5 to <12 Years
Oct 21, 2021 06:45AM Pfizer (PFE) and BioNTech (BNTX) Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine
Oct 21, 2021 06:45AM Pfizer (PFE) and BioNTech SE (BNTX) Report Phase 3 Data Confirming High Efficacy of a Booster Dose of Their COVID-19 Vaccine
Oct 21, 2021 06:45AM Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine
Oct 21, 2021 06:45AM Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine
Oct 20, 2021 04:22PM Pfizer (PFE) Announces Advisory Committee on Immunization Practices Votes to Recommend Routine Use of Pfizer’s PREVNAR 20 in Adults
Oct 20, 2021 04:19PM Advisory Committee on Immunization Practices Votes to Recommend Routine Use of Pfizer’s PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) in Adults
Oct 19, 2021 06:58AM Myovant Sciences (MYOV) and Pfizer (PFE) Report Data on Relugolix Combination Therapy from Studies in Uterine Fibroids and Endometriosis
Oct 19, 2021 06:58AM Myovant Sciences and Pfizer Present Data on Relugolix Combination Therapy from Studies in Uterine Fibroids and Endometriosis at the American Society for Reproductive Medicine Congress
Oct 19, 2021 06:58AM Myovant Sciences and Pfizer Present Data on Relugolix Combination Therapy from Studies in Uterine Fibroids and Endometriosis at the American Society for Reproductive Medicine Congress
Oct 15, 2021 07:50AM Pfizer (PFE) Announces Abrocitinib Receives Positive CHMP Opinion for the Treatment of Adults with Moderate to Severe Atopic Dermatitis
Oct 15, 2021 07:50AM Pfizer’s Abrocitinib Receives Positive CHMP Opinion for the Treatment of Adults with Moderate to Severe Atopic Dermatitis
Oct 13, 2021 12:35AM Data suggests mRNA booster dose generates stronger antibody response after J&J shot - Axios
Oct 7, 2021 08:26AM Pfizer, BioNTech seek U.S. COVID-19 vaccine clearance for children 5-11
Oct 6, 2021 07:01AM Voyager Therapeutics (VYGR) Announces License Option Agreement with Pfizer (PFE) for Next-Generation TRACERᵀᴹ AAV Capsids to Enable Neurologic and Cardiovascular Gene Therapy Programs
Oct 6, 2021 07:00AM Voyager Therapeutics Announces License Option Agreement with Pfizer for Next-Generation TRACERᵀᴹ AAV Capsids to Enable Neurologic and Cardiovascular Gene Therapy Programs
Sep 30, 2021 06:47AM Pfizer (PFE) Announces Japan’s MHLW Approves CIBINQO for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Sep 30, 2021 06:45AM Japan’s MHLW Approves Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Sep 29, 2021 06:45AM Pfizer (PFE) Announces Positive Top-line Results of Phase 3 Study Exploring Coadministration of Prevnar 20 With Seasonal Flu Vaccine in Older Adults Released
View More Recent Stories View Older Stories